Wire report

Why you've probably been thinking about narcolepsy all wrong

The sleep disorder has been the butt of jokes and a comedic plot point, but the reality of living with narcolepsy is anything but funny. Things could be about to change for people with the condition though, after the US Food and Drug Administration (FDA) approved the first ever drug to treat narcolepsy itself, rather than just its symptoms. Madeleine Finlay tells Ian Sample how the scientific breakthrough came about, and Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, explains what it is like to live with the condition and how the drug could be gamechanger Continue reading...

Image from linked report: Why you've probably been thinking about narcolepsy all wrong
Image from the linked report: Why you've probably been thinking about narcolepsy all wrong.Credit: The Guardian Thumbnail shown with attribution and outbound source link; VINI does not claim ownership or republish the original article body. Image source Image shown with attribution and an outbound source link; VINI does not claim ownership or republish the original article body.
Reading time2 min

coverage / Wire report

Reader toolsFollow the reporting.

Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.

FollowGet story updatesBriefs and topic returnsContextOpen background1 public sourceContributeSend recordsDocuments, dates, photosSupportFund reportingReader-backed workShareCopy story URLvininews.com
Why it mattersScience

The sleep disorder has been the butt of jokes and a comedic plot point, but the reality of living with narcolepsy is anything but funny. Things could be about to change for people with the condition though, after the US Food and Drug Administration (FDA) approved the first ever drug to treat narcolepsy itself, rather than just its symptoms. Madeleine Finlay tells Ian Sample how the scientific breakthrough came about, and Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, explains what it is like to live with the condition and how the drug could be gamechanger Continue reading...

What to know1 source

Check the original link, updates, and responses when a detail is contested.

Keep readingmedical

Open topic or search related wording such as records, sources, agencies, dates, and locations.

What happened

According to The Guardian’s source item, Why you’ve probably been thinking about narcolepsy all wrong, The sleep disorder has been the butt of jokes and a comedic plot point, but the reality of living with narcolepsy is anything but funny. Things could be about to change for people with the condition though, after the US Food and Drug Administration (FDA) approved the first ever drug to treat narcolepsy itself, rather than just its symptoms. Madeleine Finlay tells Ian Sample how the scientific breakthrough came about, and Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, explains what it is like to live with the condition and how the drug could be gamechanger Continue reading…

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-10-09T14:16:04+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Why you’ve probably been thinking about narcolepsy all wrong via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.

Keep following

This file can keep developing

vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.

SubscribeGet the next updateSend recordsShare documents or leadsRespondRequest comment or replyDonateSupport reporting costs

Support and subscriptions never buy coverage, placement, suppression, or corrections.

This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.

Source links

Reader comments

Moderated discussion

Account access

Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.

Loading comments.

No approved comments yet.

Substantive, civil comments can be submitted by approved account holders.